COMBINING GENERATIONAL GENETIC AND LP(A) CASCADE TESTING TO PREDICT LP(A) AND ASSOCIATED CARDIOVASCULAR DISEASE (CVD) RISK IN YOUNG ADULTS
Therapeutic Area: ASCVD/CVD Risk Assessment Background: Like Familial Hypercholesterolemia (FH), Lp(a) ≥300nmol/L is associated with 3-4-fold increased cardiovascular risk but is more common. Cascade screening of first-degree relatives for FH has been widely accepted but not commonly used for Lp(a)....
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-03-01
|
| Series: | American Journal of Preventive Cardiology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666667722000897 |